1 recruiting, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Renal hypouricemia: new trials by email Literature Review of Renal hypouricemia trials Research Report on Renal hypouricemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease IG3018, Placebo matching IG3018 - Hyperuricemia, Hypouricemia, Renal | Phase 1 / Phase 2 | Recruiting | Intelligem Therapeutics Australia Pty Ltd. | 60 | 2024-11-12 | 2026-02-03 |
| A Randomized Clinical Trail of The Effect of Postoperative Uric Acid Control on Stone Recurrence and Renal Function in Patients With Hyperuricemia of Urolithiasis. Febuxostat 40mg Tab, Non-drug control group - Hypouricemia, Renal, Urolithiasis | Phase 4 | Unknown | Xuhui Central Hospital, Shanghai | 100 | 2020-04-10 | 2020-05-21 |
Hyperuricemia (1) · Renal Insufficiency, Chronic (1) · Urolithiasis (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Chronic Disease (1) · Disease Attributes (1) · Kidney Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1)
Febuxostat (1)
Intelligem Therapeutics Australia Pty Ltd. (1) · Xuhui Central Hospital, Shanghai (1)
Australia (1) · China (1) · Taiwan (1)